18F-PSMA-1007假阳性而18F-氟胆碱真阴性的脾血管瘤病例
一例62岁前列腺癌生化复发患者同时接受18F-PSMA-1007与18F-氟胆碱PET/CT检查,前者在盆腔和腹膜后淋巴结转移检出上优于后者,但前者显示脾脏局灶性摄取增高而后者未见。该18F-PSMA-1007摄取灶对应10年前MRI已发现且大小未变的脾血管瘤,提示报告时需警惕此 pitfalls。
要点
- 18F-PSMA-1007可在脾血管瘤中表现为假阳性摄取。
- 18F-氟胆碱PET/CT对同一脾血管瘤未见摄取。
- 18F-PSMA-1007对盆腔和腹膜后淋巴结转移检出优于18F-氟胆碱。
核心结论
- 18F-PSMA-1007 PET/CT在脾血管瘤中可出现假阳性摄取,而18F-氟胆碱PET/CT为真阴性。
研究设计与样本
- 个案报道:一例62岁前列腺癌生化复发患者先后接受18F-PSMA-1007与18F-氟胆碱PET/CT检查。
主要发现
- 18F-PSMA-1007 PET/CT在盆腔和腹膜后淋巴结转移检出上优于18F-氟胆碱PET/CT。
- 18F-PSMA-1007显示脾脏局灶性摄取增高,而18F-氟胆碱未见该摄取。
- 该18F-PSMA-1007摄取灶对应脾血管瘤,为10年前MRI首次发现且大小未变。
临床怎么用
- 阅18F-PSMA-1007 PET/CT报告时,应将脾脏局灶性摄取增高纳入脾血管瘤假阳性的鉴别诊断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 62-year-old man with prostate cancer underwent both F-PSMA-1007 and F-fluorocholine PET/CT studies for biochemical recurrence. F-PSMA-1007 PET/CT outperformed F-fluorocholine PET/CT in detecting lymph node metastases in the pelvis and retroperitoneum, whereas the former showed a focus of increased uptake in the spleen not seen on F-fluorocholine. The F-PSMA-1007 -avid lesion corresponded to a splenic hemangioma, which was initially detected in an MRI scan 10 years ago, unchanged in size. This case shows different features of F-PSMA-1007 and F-fluorocholine uptake, in an incidentally detected splenic hemangioma, alerting PET/CT reports for possible pitfall.
引用
- Panagiotidis E, Paschali A, Xourgia X, et al. False-Positive 18F-PSMA-1007 and True-Negative 18F-Fluorocholine PET/CT Splenic Hemangioma. Clin Nucl Med. 2020. PMID: 33065626. doi:10.1097/RLU.0000000000003310
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。